Insights
Writing on governed AI in life sciences: what auditors ask, what acquirers ask, and what it takes to make an AI result safe to act on.
Research note
Is governed AI really a valuation driver in biotech?
What the evidence actually supports about AI governance and company value, and where the claim is weaker than the market assumes.
Article
The AI diligence file
What acquirers and partners ask about AI, and what a company should be able to produce on request.
Article
The invisible tax of shadow AI
The hidden costs when teams adopt AI tools without a shared standard for how results are produced.
Guide
Validating AI outputs in a GxP environment
A practical walk through what validation means when the output came from a model rather than an instrument.